Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
pharmaphorum6d
Lilly’s Olumiant is first JAK drug backed by NICE for eczema
Eli Lilly’s JAK inhibitor Olumiant has become the first drug in the JAK inhibitor class to be recommended for NHS use in England and Wales as a treatment for atopic dermatitis, also known as eczema.
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...
ADVFN5d
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale ...
app.com4d
Donald Trump approval rating at first 50 days. Honeymoon fades says national poll
As President Donald Trump exits his first 50 days of his second term, his current approval rating hints that Americans are deeply divided as 'the honeymoon' period fades. According to a national ...
PR Newswire2d
Photocure appoints Jane Healy as Vice President and General Manager EMEA
OSLO, Norway, March 26, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Jane Healy as Vice President and General Manager EMEA.
Bloomberg L.P.6d
FEMA Disaster Workers Need Homeland Security Secretary’s Approval to Stay on Job
Most Federal Emergency Management Agency employees will need Homeland Security Secretary Kristi Noem’s approval to stay on the job after their current terms expire, paving the way for ...
Nasdaq5d
Can-Fite Launches Pivotal Phase 3 Psoriasis Study Of Piclidenoson With FDA & EMA Approval
(RTTNews) - Can-Fite BioPharma Ltd. (CANF), Monday announced the initiation of a pivotal Phase 3 clinical study of its oral drug, Piclidenoson, for the treatment of moderate to severe plaque ...
Hoteliermiddleeast.com2d
Wyndham’s strategic growth: Expanding across EMEA
The hospitality industry is evolving at fast pace, and Wyndham Hotels & Resorts continues to grow with its robust expansion strategy across Europe, the Middle East, Eurasia, and Africa (EMEA). In 2024 ...